Achieve Life Sciences ACHV
NASDAQ ACHV
$8.49 +0.18 (+2.17%)
As of: Sep 4, 2026 · 3:59 PM EDT

Achieve Life Sciences (ACHV) Goodwill & Intangibles (2016 - 2026)

Achieve Life Sciences' (ACHV) quarterly Goodwill & Intangibles came in at $1.7 million in Q1 2026, down 11.37% YoY from $2.0 million in Q1 2025, and down 3.08% on a QoQ basis from $1.8 million in Q4 2025.

Analysis

Achieve Life Sciences (ACHV) Goodwill & Intangibles (2016 - 2026) Analysis & Trends

Achieve Life Sciences (ACHV) has 11 years of Goodwill & Intangibles data on file, last reported at $1.7 million in Q1 2026.

  • Quarterly Goodwill & Intangibles fell 11.37% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 11.37% YoY) and the FY2025 annual result came in at $1.8 million, down 11.11% from the prior year.
  • Goodwill & Intangibles eased to $1.7 million in Q1 2026, from $1.8 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $2.6 million in Q1 2022 to a low of $1.7 million in Q1 2026.
  • A 5-year average of $2.2 million and a median of $2.2 million in 2024 frame the typical range for Goodwill & Intangibles.
  • The widest YoY moves for Goodwill & Intangibles: up 7.84% in 2022, down 38.23% in 2022.
  • Tracing ACHV's Goodwill & Intangibles over 5 years: stood at $2.5 million in 2022, then retreated by 9.01% to $2.2 million in 2023, then decreased by 10.0% to $2.0 million in 2024, then retreated by 11.11% to $1.8 million in 2025, then declined by 3.08% to $1.7 million in 2026.
  • The last three Goodwill & Intangibles figures came in at $1.7 million (Q1 2026), $1.8 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Achieve Life Sciences 369.90 Mn 369.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.67 Mn
Mar 31, 2026 1.73 Mn
Dec 31, 2025 1.79 Mn
Sep 30, 2025 1.84 Mn
Jun 30, 2025 1.90 Mn
Mar 31, 2025 1.95 Mn
Dec 31, 2024 2.01 Mn
Sep 30, 2024 2.06 Mn
Jun 30, 2024 2.12 Mn
Mar 31, 2024 2.18 Mn
Dec 31, 2023 2.23 Mn
Sep 30, 2023 2.29 Mn
Jun 30, 2023 2.34 Mn
Mar 31, 2023 2.40 Mn
Dec 31, 2022 2.45 Mn
Sep 30, 2022 2.51 Mn
Jun 30, 2022 2.56 Mn
Mar 31, 2022 2.62 Mn
Dec 31, 2021 2.68 Mn
Sep 30, 2021 2.73 Mn